Previous 10 | Next 10 |
2024-05-06 10:56:49 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Harvard Bioscience Historical ear...
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. Par...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...
2024-04-09 09:28:17 ET More on Harvard Bioscience Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Harvard Bioscience Historical ear...
HOLLISTON, Mass., April 09, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of appro...
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both t...
2024-03-07 12:53:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Harvard Bioscience (NASDAQ: HBIO ) just reported results for the fourth quarter of 2023. Harvard Bioscience reported earnings per share of 4 cents. This was below the anal...
2024-03-07 09:56:04 ET Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Conference Call March 07, 2024, 08:00 AM ET Company Participants Dave Sirois - Director, SEC Reporting Jim Green - Chairman, President & Chief Executive Officer Jennifer Cote - Chief Fina...
2024-03-07 07:02:45 ET More on Harvard Bioscience Seeking Alpha’s Quant Rating on Harvard Bioscience Historical earnings data for Harvard Bioscience Financial information for Harvard Bioscience Read the full article on Seeking Alpha For further...
Q4 Revenues of $28.2 million Q4 Gross Margin of 58.0% (230 bps year-over-year improvement) Q4 operating income of $0.3 million, adjusted operating income of $ 3.3 million Strong operating cash ...
News, Short Squeeze, Breakout and More Instantly...
Harvard Bioscience Inc. Company Name:
HBIO Stock Symbol:
NASDAQ Market:
Harvard Bioscience Inc. Website:
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14 th Annual East Coast IDEAS Conference at the ...
HOLLISTON, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the Jefferies Global Healthcare Conference at the Marriot...
HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22 ...